Cargando…

Effect of Hepatitis C Drugs on Blood Coagulability in Patients on Warfarin Using the Medical Information Database Network (MID-NET(®)) in Japan

BACKGROUND: Previous studies suggested that direct-acting antivirals (DAAs) against hepatitis C increased the blood coagulability of patients on warfarin. This study aims to descriptively investigate the effects of DAAs on the blood coagulability and liver function of patients on warfarin in Japan....

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawada, Sono, Ando, Takashi, Hirano, Mai, Komiyama, Noriyuki, Iguchi, Toyotaka, Oniyama, Yukio, Ishiguro, Chieko, Uyama, Yoshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021533/ https://www.ncbi.nlm.nih.gov/pubmed/33393016 http://dx.doi.org/10.1007/s43441-020-00247-8

Ejemplares similares

Assessing the Risk of Decrease in Kidney Function in Patients Prescribed Direct-Acting Antivirals for Hepatitis C Utilizing the MID-NET(®) Medical Information Database Network in Japan
por: Hasegawa, Tomoaki, et al.
Publicado: (2022)

Use of National Database of Health Insurance Claims and Specific Health Checkups for examining practical utilization and safety signal of a drug to support regulatory assessment on postmarketing drug safety in Japan
por: Shida, Haruka, et al.
Publicado: (2023)

Nested Case‐Control Study Utilizing MID‐NET® on Thrombocytopenia Associated With Pegfilgrastim in Patients Treated With Antineoplastic Agents
por: Kajiyama, Kazuhiro, et al.
Publicado: (2021)

Cardiovascular risk of urate‐lowering drugs: A study using the National Database of Health Insurance Claims and Specific Health Checkups of Japan
por: Sawada, Sono, et al.
Publicado: (2022)

Establishment of the MID‐NET(®) medical information database network as a reliable and valuable database for drug safety assessments in Japan
por: Yamaguchi, Mitsune, et al.
Publicado: (2019)

Safety monitoring of COVID-19 vaccines in Japan
por: Yamaguchi, Toshihiro, et al.
Publicado: (2022)

Updated report of COVID-19 vaccine safety monitoring in Japan: Booster shots and paediatric vaccinations
por: Yamaguchi, Toshihiro, et al.
Publicado: (2022)

Evolving Acceptance and Use of RWE for Regulatory Decision Making on the Benefit/Risk Assessment of a Drug in Japan
por: Nishioka, Kinue, et al.
Publicado: (2021)

International Normalized Ratio Relevance to the Observed Coagulation Abnormalities in Warfarin Treatment and Disseminated Intravascular Coagulation
por: Walborn, Amanda, et al.
Publicado: (2018)

Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children
por: Yamaguchi, Toshihiro, et al.
Publicado: (2023)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

Characteristics of hospital differences in missing of clinical laboratory test results in a multi-hospital observational database contributing to MID-NET® in Japan
por: Komamine, Maki, et al.
Publicado: (2021)

How many Assertive Community Treatment Teams are Needed in Japan? Estimate from Need Survey in Sendai City
por: Nishio, Masaaki, et al.
Publicado: (2014)

Factors Affecting Drug‐Development Strategies in Asian Global Clinical Trials for Drug Approval in Japan
por: Asano, Kunihito, et al.
Publicado: (2017)

Effects of coagulation factor VII polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation and maintenance phases of warfarin therapy
por: AL-Eitan, Laith N, et al.
Publicado: (2019)

Current Status and Open Issues Concerning Global Clinical Trials (GCTs) in Japan and East Asia
por: Miyazaki, Koichi, et al.
Publicado: (2017)

Dealing with missing data in laboratory test results used as a baseline covariate: results of multi-hospital cohort studies utilizing a database system contributing to MID-NET(®) in Japan
por: Komamine, Maki, et al.
Publicado: (2023)

Monitoring of coagulation by intraoperative thromboelastometry of liver transplantation in a patient using warfarin – case report
por: Nascimento, José Carlos Rodrigues, et al.
Publicado: (2018)

An integrated epidemiological and neural net model of the warfarin effect in managed care patients
por: Jacobs, David M, et al.
Publicado: (2017)

Activation of the Non-receptor Tyrosine Kinase cSrc in Macrophage-rich Atherosclerotic Plaques of Human Carotid Arteries
por: Toi, Sono, et al.
Publicado: (2007)

Points to Consider for Implementation of the ICH E17 Guideline: Learning from Past Multiregional Clinical Trials in Japan
por: Asano, Kunihito, et al.
Publicado: (2020)

Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report
por: Iguchi, Toyotaka, et al.
Publicado: (2021)

Metabolic profiling of HepG2 cells incubated with S(−) and R(+) enantiomers of anti-coagulating drug warfarin
por: Bai, Jing, et al.
Publicado: (2010)

Aortic Aneurysm-associated Disseminated Intravascular Coagulation that Responded Well to a Switch from Warfarin to Rivaroxaban
por: Kadohira, Yasuko, et al.
Publicado: (2017)

Time Trends in Disseminated Intravascular Coagulation in Japan
por: Kurokawa, Mineo
Publicado: (2020)

Transthyretin-related familial amyloidotic polyneuropathy—Progress in Kumamoto, Japan (1967–2010)—
por: ARAKI, Shukuro, et al.
Publicado: (2010)

Effect of Recombinant Human Soluble Thrombomodulin on Coagulation-Related Variables in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Retrospective Observational Study
por: Mitaka, Chieko, et al.
Publicado: (2021)

Confirmation of warfarin resistance of naturally occurring VKORC1 variants by coexpression with coagulation factor IX and in silico protein modelling
por: Müller, Elisabeth, et al.
Publicado: (2014)

Anti-coagulation Drug Warfarin Contributes to Severe Adverse Outcomes in Prolonged Unsupervised Use: A Double-edged Sword
por: Ordookhanian, Christ, et al.
Publicado: (2018)

Effectiveness of a Third Dose of COVID-19 mRNA Vaccine During the Omicron BA.1- and BA.2-Predominant Periods in Japan: The VENUS Study
por: Mimura, Wataru, et al.
Publicado: (2022)

A summary of the Japan septic disseminated intravascular coagulation study
por: Hayakawa, Mineji, et al.
Publicado: (2018)

Real‐world evidence on disseminated intravascular coagulation from Japan
por: Hisamune, Ryo, et al.
Publicado: (2023)

Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of Delta and Omicron variant predominance in Japan: the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study
por: Mimura, Wataru, et al.
Publicado: (2022)

Warfarin overactivity
por: Yamanel, L, et al.
Publicado: (2005)

Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care
por: Allan, Victoria, et al.
Publicado: (2017)

First Nationwide Survey of 199 Patients with Amyloid A Amyloidosis in Japan
por: Okuda, Yasuaki, et al.
Publicado: (2018)

Relationship Between Teams’ Leader–Member Exchange Characteristics and Psychological Outcomes for Nurses and Nurse Managers: A Cross-Sectional Study in Japan
por: Kawaguchi, Saeka, et al.
Publicado: (2021)

Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
por: Molteni, Mauro, et al.
Publicado: (2014)

Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile
por: Di Maso, Vittorio, et al.
Publicado: (2014)

Influence of Sampling on the Determination of Warfarin and Warfarin Alcohols in Oral Fluid
por: Lomonaco, Tommaso, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7gba0smcmapc2q8hpf38ga82cn